{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T05:55:22Z","timestamp":1775109322196,"version":"3.50.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100023280","name":"Seqirus","doi-asserted-by":"publisher","award":["96966741"],"award-info":[{"award-number":["96966741"]}],"id":[{"id":"10.13039\/501100023280","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["K12HD113189"],"award-info":[{"award-number":["K12HD113189"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Ther"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s40121-026-01310-x","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T15:47:07Z","timestamp":1772725627000},"page":"1093-1114","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mitigating Vaccine Disparities Through Faith-Based Intervention: A Pre-Post Analysis of Recombinant Zoster Vaccine Knowledge and Acceptance in Socially Vulnerable Racial and Ethnic Minoritized Communities"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4162-6408","authenticated-orcid":false,"given":"Jacinda C.","family":"Abdul-Mutakabbir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raheem","family":"Abdul-Mutakabbir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel J.","family":"Casey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,5]]},"reference":[{"key":"1310_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2025.127503","volume":"62","author":"J Lin","year":"2025","unstructured":"Lin J, Dai Z, Li C, He W-Q. Change in herpes zoster vaccination uptake before and during the COVID-19 pandemic in the United States older adults. Vaccine. 2025;62:127503.","journal-title":"Vaccine"},{"issue":"9","key":"1310_CR2","doi-asserted-by":"publisher","first-page":"e3210","DOI":"10.1093\/cid\/ciaa1185","volume":"73","author":"RR Thompson","year":"2021","unstructured":"Thompson RR, Kong CL, Porco TC, Kim E, Ebert CD, Acharya NR. Herpes zoster and postherpetic neuralgia: changing incidence rates from 1994 to 2018 in the United States. Clin Infect Dis. 2021;73(9):e3210\u20137.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"1310_CR3","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12877-017-0420-9","volume":"17","author":"L Varghese","year":"2017","unstructured":"Varghese L, Standaert B, Olivieri A, Curran D. The temporal impact of aging on the burden of herpes zoster. BMC Geriatr. 2017;17(1):30.","journal-title":"BMC Geriatr"},{"issue":"3","key":"1310_CR4","doi-asserted-by":"publisher","first-page":"274","DOI":"10.4065\/84.3.274","volume":"84","author":"P Sampathkumar","year":"2009","unstructured":"Sampathkumar P, Drage LA, Martin DP. Herpes zoster (shingles) and postherpetic neuralgia. Mayo Clin Proc. 2009;84(3):274\u201380.","journal-title":"Mayo Clin Proc"},{"key":"1310_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare13192495","author":"HI AlSaif","year":"2025","unstructured":"AlSaif HI, AlMuaawi L, Alsenani S, Aldalaqan N, Mulia Y, Alqazlan F, et al. Uptake, willingness, and determinants of herpes zoster vaccination in adults with chronic diseases in Riyadh, Saudi Arabia. Healthcare (Basel). 2025. https:\/\/doi.org\/10.3390\/healthcare13192495.","journal-title":"Healthcare (Basel)"},{"key":"1310_CR6","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.2147\/JPR.S501674","volume":"18","author":"X Yang","year":"2025","unstructured":"Yang X, Li D, Chen Y, Zhang X, Zhao Q. Exploring the link between diabetes, herpes zoster, and post-herpetic neuralgia: insights from Mendelian randomization. J Pain Res. 2025;18:1479\u201389.","journal-title":"J Pain Res"},{"issue":"2","key":"1310_CR7","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1002\/art.39855","volume":"69","author":"LH Calabrese","year":"2017","unstructured":"Calabrese LH, Xie F, Yun H, Winthrop KL, Baddley JW, Calabrese C, et al. Herpes zoster and the risk of stroke in patients with autoimmune diseases. Arthritis Rheumatol. 2017;69(2):439\u201346.","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"1310_CR8","doi-asserted-by":"publisher","first-page":"E275","DOI":"10.1503\/cmaj.101137","volume":"183","author":"YW Yang","year":"2011","unstructured":"Yang YW, Chen YH, Wang KH, Wang CY, Lin HW. Risk of herpes zoster among patients with chronic obstructive pulmonary disease: a population-based study. CMAJ. 2011;183(5):E275\u201380.","journal-title":"CMAJ"},{"issue":"1","key":"1310_CR9","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/s41541-023-00757-0","volume":"8","author":"D Curran","year":"2023","unstructured":"Curran D, Doherty TM, Lecrenier N, Breuer T. Healthy ageing: herpes zoster infection and the role of zoster vaccination. NPJ Vaccines. 2023;8(1):184.","journal-title":"NPJ Vaccines"},{"key":"1310_CR10","doi-asserted-by":"publisher","first-page":"5771","DOI":"10.2147\/IDR.S554037","volume":"18","author":"T T\u00fcz\u00fcn","year":"2025","unstructured":"T\u00fcz\u00fcn T. Complications and antiviral strategies in herpes zoster: a retrospective evaluation of 50 patients treated in a secondary care setting. Infect Drug Resist. 2025;18:5771\u201380.","journal-title":"Infect Drug Resist"},{"key":"1310_CR11","doi-asserted-by":"crossref","unstructured":"Cunningham AL, McIntyre P, Subbarao K, Booy R, Levin MJ. Vaccines for older adults. BMJ. 2021;372.","DOI":"10.1136\/bmj.n188"},{"issue":"44","key":"1310_CR12","first-page":"1528","volume":"60","author":"Update on herpes zoster vaccine","year":"2011","unstructured":"Update on herpes zoster vaccine. Licensure for persons aged 50 through 59 years. MMWR Morb Mortal Wkly Rep. 2011;60(44):1528.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1310_CR13","doi-asserted-by":"crossref","unstructured":"Dooling K, Guo A, Patel M. Morbidity and mortality weekly report recommendations of the advisory committee on immunization practices for use of herpes zoster vaccines. Morbidity and Mortality Weekly Report. 2018;67.","DOI":"10.15585\/mmwr.mm6703a5"},{"issue":"23","key":"1310_CR14","doi-asserted-by":"publisher","first-page":"3493","DOI":"10.1016\/j.vaccine.2023.04.067","volume":"41","author":"CY Lewis","year":"2023","unstructured":"Lewis CY, Mishra K, Sun Y, Sechrist SJ, Arnold BF, Acharya NR. Recombinant zoster vaccine coverage in the United States: an analysis of claims-based data. Vaccine. 2023;41(23):3493\u20136.","journal-title":"Vaccine"},{"issue":"2","key":"1310_CR15","doi-asserted-by":"publisher","first-page":"189","DOI":"10.7326\/M23-2023","volume":"177","author":"O Zerbo","year":"2024","unstructured":"Zerbo O, Bartlett J, Fireman B, Lewis N, Goddard K, Dooling K, et al. Effectiveness of recombinant zoster vaccine against herpes zoster in a real-world setting. Ann Intern Med. 2024;177(2):189\u201395.","journal-title":"Ann Intern Med"},{"issue":"3","key":"1310_CR16","doi-asserted-by":"publisher","first-page":"80","DOI":"10.15585\/mmwr.mm7103a2","volume":"71","author":"TC Anderson","year":"2022","unstructured":"Anderson TC, Masters NB, Guo A, Shepersky L, Leidner AJ, Lee GM, et al. Use of Recombinant Zoster Vaccine in Immunocompromised Adults Aged \u226519 Years: recommendations of the advisory committee on immunization practices - United States, 2022. MMWR Morb Mortal Wkly Rep. 2022;71(3):80\u20134.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1310_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines13050477","author":"M Oleszko","year":"2025","unstructured":"Oleszko M, Zapolnik P, Czajka H. Herpes zoster vaccination: insights into efficacy, safety, and guidelines. Vaccines. 2025. https:\/\/doi.org\/10.3390\/vaccines13050477.","journal-title":"Vaccines"},{"issue":"1","key":"1310_CR18","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2025.2525603","volume":"21","author":"Y Li","year":"2025","unstructured":"Li Y, Xia H, Zhang H, Lu Y, Zhou H, Yu R, et al. The safety of co-administration of recombinant zoster vaccine (Shingrix) and influenza vaccines in the elderly in VAERS during 2018-2024. Hum Vaccin Immunother. 2025;21(1):2525603.","journal-title":"Hum Vaccin Immunother"},{"key":"1310_CR19","unstructured":"Medicare.gov. Shingles shots [Available from: https:\/\/www.medicare.gov\/coverage\/shingles-shots#:~:text=painful%20skin%20rash.-,Costs,copayment."},{"issue":"6","key":"1310_CR20","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1177\/19427891251392576","volume":"28","author":"D Singer","year":"2025","unstructured":"Singer D, Stempniewicz N, Lee L, Evans K, Huse S, Berger A. Disparities in recombinant zoster vaccine coverage in the United States. Popul Health Manag. 2025;28(6):288\u201397.","journal-title":"Popul Health Manag"},{"key":"1310_CR21","unstructured":"Jatlaoui T, Hung M, Srivastav A, Lu P, Black C, Lindley M, et al. Vaccination coverage among adults in the United States, National Health Interview Survey, 2019\u20132020. 2021."},{"key":"1310_CR22","doi-asserted-by":"crossref","unstructured":"Stempniewicz N SA, Zhu Y, et al. Incidence of diagnosed herpes zoster and risk of complications by race and ethnicity: a retrospective cohort study among adults in the United States. Open Forum Infect Dis. 2025;12(Suppl 1):ofae631.2495.","DOI":"10.1093\/ofid\/ofae631.2495"},{"key":"1310_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmedr.2023.102319","volume":"35","author":"C Vardavas","year":"2023","unstructured":"Vardavas C, Nikitara K, Aslanoglou K, Lagou I, Marou V, Phalkey R, et al. Social determinants of health and vaccine uptake during the first wave of the COVID-19 pandemic: a systematic review. Prev Med Rep. 2023;35:102319.","journal-title":"Prev Med Rep"},{"issue":"3","key":"1310_CR24","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1080\/21645515.2017.1376152","volume":"14","author":"SC Quinn","year":"2018","unstructured":"Quinn SC. African American adults and seasonal influenza vaccination: changing our approach can move the needle. Hum Vaccin Immunother. 2018;14(3):719\u201323.","journal-title":"Hum Vaccin Immunother"},{"issue":"34","key":"1310_CR25","first-page":"4212","volume":"33","author":"S Goldstein","year":"2015","unstructured":"Goldstein S, MacDonald NE, Guirguis S. Hesitancy SWGoV. Health Commun Vaccine Hesitancy Vaccine. 2015;33(34):4212\u20134.","journal-title":"Health Commun Vaccine Hesitancy Vaccine"},{"key":"1310_CR26","unstructured":"Community Hospital of San Bernardino. Community Health Needs Assessment & Plan [Available from: https:\/\/www.dignityhealth.org\/socal\/locations\/san-bernardino\/about-us\/serving-the-community\/community-health-needs-assessment-plan."},{"key":"1310_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-025-01188-1","author":"JC Abdul-Mutakabbir","year":"2025","unstructured":"Abdul-Mutakabbir JC, Abdul-Mutakabbir R. Syndemics of antimicrobial resistance: non-communicable diseases, social deprivation, and the rise of multidrug-resistant infections. Infect Dis Ther. 2025. https:\/\/doi.org\/10.1007\/s40121-025-01188-1.","journal-title":"Infect Dis Ther"},{"key":"1310_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(21)00099-1","author":"JC Abdul-Mutakabbir","year":"2021","unstructured":"Abdul-Mutakabbir JC, Casey S, Jews V, King A, Simmons K, Hogue MD, et al. A three-tiered approach to address barriers to COVID-19 vaccine delivery in the Black community. Lancet Glob Health. 2021. https:\/\/doi.org\/10.1016\/S2214-109X(21)00099-1.","journal-title":"Lancet Glob Health"},{"issue":"8","key":"1310_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10081364","volume":"10","author":"JC Abdul-Mutakabbir","year":"2022","unstructured":"Abdul-Mutakabbir JC, Granillo C, Peteet B, Dubov A, Montgomery SB, Hutchinson J, et al. Rapid implementation of a community\u2013academic partnership model to promote COVID-19 vaccine equity within racially and ethnically minoritized communities. Vaccines. 2022;10(8):1364.","journal-title":"Vaccines"},{"issue":"7","key":"1310_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10071039","volume":"10","author":"B Peteet","year":"2022","unstructured":"Peteet B, Watts V, Tucker E, Brown P, Hanna M, Saddlemire A, et al. Faith, fear, and facts: a COVID-19 vaccination hesitancy intervention for Black church congregations. Vaccines. 2022;10(7):1039.","journal-title":"Vaccines"},{"issue":"2","key":"1310_CR31","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/idr17020018","volume":"17","author":"JC Abdul-Mutakabbir","year":"2025","unstructured":"Abdul-Mutakabbir JC, Abdul-Mutakabbir R, Casey SJ. Utilizing an educational intervention to enhance influenza vaccine literacy and acceptance among minoritized adults in Southern Californian vulnerable communities in the post-COVID-19 era. Infect Dis Rep. 2025;17(2):18.","journal-title":"Infect Dis Rep"},{"key":"1310_CR32","unstructured":"Control CfD. CDC Social Vulnerability Index."},{"issue":"1","key":"1310_CR33","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s11908-025-00869-9","volume":"27","author":"JC Abdul-Mutakabbir","year":"2025","unstructured":"Abdul-Mutakabbir JC. Area-based deprivation indices and healthcare-associated infections: a narrative review of evidence. Curr Infect Dis Rep. 2025;27(1):20.","journal-title":"Curr Infect Dis Rep"},{"issue":"10","key":"1310_CR34","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1097\/01.JAA.0000873832.52485.65","volume":"35","author":"F Gutierrez","year":"2022","unstructured":"Gutierrez F, Wolfe J. Using the health belief model to improve influenza vaccination rates. JAAPA. 2022;35(10):46\u20137.","journal-title":"JAAPA"},{"key":"1310_CR35","unstructured":"Team RC. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing 2024."},{"issue":"10","key":"1310_CR36","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1038\/s41591-024-03201-5","volume":"30","author":"M Taquet","year":"2024","unstructured":"Taquet M, Dercon Q, Todd JA, Harrison PJ. The recombinant shingles vaccine is associated with lower risk of dementia. Nat Med. 2024;30(10):2777\u201381.","journal-title":"Nat Med"},{"issue":"23","key":"1310_CR37","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.027451","volume":"11","author":"SG Curhan","year":"2022","unstructured":"Curhan SG, Kawai K, Yawn B, Rexrode KM, Rimm EB, Curhan GC. Herpes zoster and long-term risk of cardiovascular disease. J Am Heart Assoc. 2022;11(23):e027451.","journal-title":"J Am Heart Assoc"},{"issue":"11","key":"1310_CR38","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1080\/21645515.2017.1368600","volume":"13","author":"C Mu\u00f1oz-Quiles","year":"2017","unstructured":"Mu\u00f1oz-Quiles C, L\u00f3pez-Lacort M, Ampudia-Blasco FJ, D\u00edez-Domingo J. Risk and impact of herpes zoster on patients with diabetes: a population-based study, 2009\u20132014. Hum Vaccin Immunother. 2017;13(11):2606\u201311.","journal-title":"Hum Vaccin Immunother"},{"issue":"6","key":"1310_CR39","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1177\/26350106251371085","volume":"51","author":"CM Okoh","year":"2025","unstructured":"Okoh CM, Moczygemba LR, Brown C, Thurman W, Avance\u00f1a ALV, Rush S. Factors impacting pneumococcal vaccination among non-Hispanic Black adults with type 2 diabetes: a nationwide cross-sectional study. Sci Diabetes Self Manag Care. 2025;51(6):658\u201373.","journal-title":"Sci Diabetes Self Manag Care"},{"issue":"11","key":"1310_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003826","volume":"18","author":"C Bhanu","year":"2021","unstructured":"Bhanu C, Gopal DP, Walters K, Chaudhry UAR. Vaccination uptake amongst older adults from minority ethnic backgrounds: a systematic review. PLoS Med. 2021;18(11):e1003826.","journal-title":"PLoS Med"},{"issue":"4","key":"1310_CR41","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1080\/10410230902889258","volume":"24","author":"KA Cameron","year":"2009","unstructured":"Cameron KA, Rintamaki LS, Kamanda-Kosseh M, Noskin GA, Baker DW, Makoul G. Using theoretical constructs to identify key issues for targeted message design: African American seniors\u2019 perceptions about influenza and influenza vaccination. Health Commun. 2009;24(4):316\u201326.","journal-title":"Health Commun"},{"key":"1310_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/currents.outbreaks.3e4a5ea39d8620494e2a2c874a3c4201","author":"S Quinn","year":"2016","unstructured":"Quinn S, Jamison A, Musa D, Hilyard K, Freimuth V. Exploring the continuum of vaccine hesitancy between African American and White adults: results of a qualitative study. PLoS Curr. 2016. https:\/\/doi.org\/10.1371\/currents.outbreaks.3e4a5ea39d8620494e2a2c874a3c4201.","journal-title":"PLoS Curr"},{"issue":"4","key":"1310_CR43","doi-asserted-by":"publisher","first-page":"e205","DOI":"10.1093\/geront\/gnw193","volume":"58","author":"JL Travers","year":"2018","unstructured":"Travers JL, Schroeder KL, Blaylock TE, Stone PW. Racial\/ethnic disparities in influenza and pneumococcal vaccinations among nursing home residents: a systematic review. Gerontologist. 2018;58(4):e205\u201317.","journal-title":"Gerontologist"},{"issue":"2","key":"1310_CR44","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1111\/j.1475-6773.2005.0e371.x","volume":"40","author":"PL Hebert","year":"2005","unstructured":"Hebert PL, Frick KD, Kane RL, McBean AM. The causes of racial and ethnic differences in influenza vaccination rates among elderly Medicare beneficiaries. Health Serv Res. 2005;40(2):517\u201338.","journal-title":"Health Serv Res"},{"issue":"1","key":"1310_CR45","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3122\/jabfm.2013.01.120154","volume":"26","author":"T Joon Lee","year":"2013","unstructured":"Joon Lee T, Hayes S, Cummings DM, Cao Q, Carpenter K, Heim L, et al. Herpes zoster knowledge, prevalence, and vaccination rate by race. J Am Board Fam Med. 2013;26(1):45\u201351.","journal-title":"J Am Board Fam Med"},{"issue":"6","key":"1310_CR46","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1080\/14760584.2021.1910502","volume":"20","author":"BJ Patterson","year":"2021","unstructured":"Patterson BJ, Myers K, Stewart A, Mange B, Hillson EM, Poulos C. Preferences for herpes zoster vaccination among adults aged 50 years and older in the United States: results from a discrete choice experiment. Expert Rev Vaccin. 2021;20(6):729\u201341.","journal-title":"Expert Rev Vaccin"},{"key":"1310_CR47","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.pec.2022.09.013","volume":"106","author":"KA Fisher","year":"2023","unstructured":"Fisher KA, Nguyen N, Fouayzi H, Singh S, Crawford S, Mazor KM. Impact of a physician recommendation on COVID-19 vaccination intent among vaccine hesitant individuals. Patient Educ Couns. 2023;106:107\u201312.","journal-title":"Patient Educ Couns"},{"issue":"1","key":"1310_CR48","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2023.2300848","volume":"20","author":"C Isonne","year":"2024","unstructured":"Isonne C, Iera J, Sciurti A, Renzi E, De Blasiis MR, Marzuillo C, et al. How well does vaccine literacy predict intention to vaccinate and vaccination status? A systematic review and meta-analysis. Hum Vaccin Immunother. 2024;20(1):2300848.","journal-title":"Hum Vaccin Immunother"},{"issue":"15","key":"1310_CR49","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1016\/j.vaccine.2023.02.059","volume":"41","author":"EE Hurstak","year":"2023","unstructured":"Hurstak EE, Paasche-Orlow MK, Hahn EA, Henault LE, Taddeo MA, Moreno PI, et al. The mediating effect of health literacy on COVID-19 vaccine confidence among a diverse sample of urban adults in Boston and Chicago. Vaccine. 2023;41(15):2562\u201371.","journal-title":"Vaccine"},{"key":"1310_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/ijph.2023.1605606","volume":"68","author":"E Zhang","year":"2023","unstructured":"Zhang E, Dai Z, Wang S, Wang X, Zhang X, Fang Q. Vaccine literacy and vaccination: a systematic review. Int J Public Health. 2023;68:1605606.","journal-title":"Int J Public Health"},{"issue":"1","key":"1310_CR51","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2025.2524247","volume":"21","author":"Y Zhu","year":"2025","unstructured":"Zhu Y, Tao Z, Feng H, Xu Q, Chen L, Ding S, et al. Vaccination coverage, willingness and determinants of herpes zoster vaccine among individuals aged 50 and above in Ningbo, China: a population-based cross-sectional study. Hum Vaccin Immunother. 2025;21(1):2524247.","journal-title":"Hum Vaccin Immunother"},{"issue":"3","key":"1310_CR52","doi-asserted-by":"publisher","first-page":"385","DOI":"10.2105\/AJPH.2018.304939","volume":"109","author":"LC Brewer","year":"2019","unstructured":"Brewer LC, Williams DR. We\u2019ve come this far by faith: the role of the Black church in public health. Am J Public Health. 2019;109(3):385\u20136.","journal-title":"Am J Public Health"},{"key":"1310_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.100834","volume":"34","author":"B Peteet","year":"2021","unstructured":"Peteet B, Belliard JC, Abdul-Mutakabbir J, Casey S, Simmons K. Community-academic partnerships to reduce COVID-19 vaccine hesitancy in minoritized communities. EClinicalMedicine. 2021;34:100834.","journal-title":"EClinicalMedicine"},{"key":"1310_CR54","doi-asserted-by":"crossref","unstructured":"Marcelin JR, Swartz TH, Bernice F, Berthaud V, Christian R, da Costa C, et al., editors. Addressing and inspiring vaccine confidence in Black, Indigenous, and People of Color (BIPOC) during the COVID-19 pandemic. Open Forum Infectious Diseases; 2021.","DOI":"10.1093\/ofid\/ofab417"},{"issue":"1","key":"1310_CR55","doi-asserted-by":"publisher","first-page":"2518636","DOI":"10.1080\/21645515.2025.2518636","volume":"21","author":"T Sommers","year":"2025","unstructured":"Sommers T, Dockery M, Burke N, D\u2019Souza S, Troupe B, Agbonyinma T, et al. Building trust and equity in vaccine communication through community engagement. Hum Vaccin Immunother. 2025;21(1):2518636.","journal-title":"Hum Vaccin Immunother"}],"container-title":["Infectious Diseases and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-026-01310-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40121-026-01310-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-026-01310-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T04:36:06Z","timestamp":1775104566000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40121-026-01310-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,5]]},"references-count":55,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["1310"],"URL":"https:\/\/doi.org\/10.1007\/s40121-026-01310-x","relation":{},"ISSN":["2193-8229","2193-6382"],"issn-type":[{"value":"2193-8229","type":"print"},{"value":"2193-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,5]]},"assertion":[{"value":"19 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Jacinda C. Abdul-Mutakabbir is an Advisory Board member of Infectious Diseases and Therapy. Jacinda C. Abdul-Mutakabbir was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Jacinda C. Abdul-Mutakabbir received an honorarium from Shionogi, GSK, and Pfizer. All other authors (Raheem Abdul-Mutakabbir and Samuel J. Casey) have no conflicts to report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration. The University of California, San Diego Institutional Review Board approved this study (#807857) and the waiver of informed consent, given the minimal risk and an anonymous collection of the data. Since the data were collected anonymously, the study was exempt from full board review.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}